Fibrosis-Directed MASH Therapeutics Enter the Approved-Drug Era
Analysis Gastroenterology / Hepatology Confirmatory Grade: Low
Li F, Li H, Juramt D, et al.
Jul 2, 2026 · Published in: BMJ Open Gastroenterology
MASLD leads global liver disease, now with targeted therapies emerging.
IV Thrombolysis Before Thrombectomy Improves Recanalization in Extended Window
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Nicolini E, Ciacciarelli A, Pracucci G, et al.
Jul 2, 2026 · Published in: European Journal of Neurology
IVT pre-MT improves stroke recanalization success post-4.5 hours.
Factor XIa Inhibitors: Indication-Specific Anticoagulation, Not Broad DOAC Replacement
Analysis Cardiology / Anticoagulation Hypothesis-generating Grade: Low
Kidder E, Dhanesha N
Jul 1, 2026 · Published in: Current Opinion in Hematology
Factor XIa inhibitors could transform thrombosis prevention.
REMAP-CAP: Ivermectin Fails to Help Hospitalized COVID-19 Patients
Analysis Critical Care / ICU Confirmatory Grade: Low
Hashmi M, Haniffa R, Jayakumar D, et al.
Jul 1, 2026 · Published in: Critical Care Medicine
Ivermectin fails to enhance survival in hospitalized COVID-19 cases.
Sepsis survivors carry elevated psychiatric risk for five years
Analysis Critical Care / ICU Confirmatory Grade: Moderate
Wetterberg H, Nilsson A, Linder A, et al.
Jul 1, 2026 · Published in: Critical Care Medicine
Sepsis survivors face an increased risk of developing psychiatric disorders.
Nonintervention Matches Ibuprofen for Preterm PDA at Two Years
Analysis Pediatric Pharmacy Hypothesis-generating Grade: Low
Sung SI, Yang M, Ahn SY, et al.
Jul 1, 2026 · Published in: Journal of Korean Medical Science
Is early PDA closure in preemies really necessary?
Invasive Candidiasis in the ICU: Diagnosis, Echinocandins, Resistance
Analysis Critical Care / ICU Confirmatory Grade: Low
Pérez MA, Hoffmann WJ, Pérez JC, et al.
Jun 30, 2026 · Published in: Chest
Invasive candidiasis is a deadly ICU complication needing swift action.
SGLT2 Inhibitor Uptake Rises but Misses Highest-Risk HFrEF Patients
Analysis Cardiology / Anticoagulation Hypothesis-generating Grade: Low
Pulatov O, Kim SY, Grossman Z, et al.
Jun 29, 2026 · Published in: BMC Cardiovascular Disorders
In-hospital SGLT2 initiation slashes heart failure readmissions.
MRAs and Low-Ceiling Diuretics Drive Potassium Shifts in Elderly Polypharmacy
Analysis Medication Safety Hypothesis-generating Grade: Low
Laurentius T, Al-Musawer E, Schmitz K, et al.
Jun 27, 2026 · Published in: BMC Geriatrics
Potassium imbalances are common in older patients on multiple drugs.
Targeted Therapy Evolution: From Kinase Inhibitors to Protein Degraders
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low
Wang Y, Tang SC
Jun 27, 2026 · Published in: Critical Reviews in Oncology/hematology
Targeted cancer therapies revolutionize personalized oncology treatment.
Ivonescimab Beats Tislelizumab on Survival in Squamous Lung Cancer
Analysis Oncology Pharmacy Practice-changing Grade: High
Lu S, Liu B, Luo Y, et al.
Jun 27, 2026 · Published in: Lancet (London, England)
Ivonescimab enhances survival in squamous NSCLC, offering new hope.
Brain-Focused Critical Care Expands Beyond the NICU
Analysis Critical Care / ICU Hypothesis-generating Grade: Low
Morag S, Bernstein T, Jones MB, et al.
Jun 27, 2026 · Published in: European Journal of Pediatrics
Shifting pediatric critical care towards brain-focused outcomes.
Variant-Stratified ALK Inhibitor Selection in EML4-ALK Lung Cancer
Analysis Oncology Pharmacy Confirmatory Grade: Low
Li S, Bao L, Zhou D, et al.
Jun 26, 2026 · Published in: Technology in Cancer Research & Treatment
EML4-ALK fusion: A precision target in NSCLC fraught with resistance challenges.
Pharmacist audit-feedback raises surgical prophylaxis compliance in Vietnam
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Low
Nguyen DT, Tran SN, Nguyen TTH, et al.
Jun 26, 2026 · Published in: PLOS One
Pharmacist-led interventions boost antibiotic compliance in surgery.
ECIL-10 Reshapes Febrile Neutropenia Antibiotic Strategy Around Stewardship
Guideline Infectious Disease / Antimicrobials Practice-changing Grade: Moderate
Averbuch D, Vanbiervliet Y, Baccelli F, et al.
Jun 25, 2026 · Published in: The Lancet. Infectious Diseases
Rising resistance challenges febrile neutropenia treatment in hematologic patients.